Peter Lynch · Growth at a reasonable price (GARP)
Is Alnylam Pharmaceuticals, Inc. (ALNY) a Peter Lynch Stock?
Strong GARP candidate: growth at a reasonable price.
79/100
Correspond
3/6 critères validés
Les critères de Peter Lynch, appliqués à ALNY
PEG ≤ 1.0
clé-
EPS CAGR ≥ 15%
clé-
Revenue CAGR ≥ 10%
44.8%
Net margin > 0
13.5%
Comment ALNY se classe selon d'autres stratégies
Données financières en direct
Cap. boursière
$29.4B
PER (TTM)
68.1x
ROIC (TTM)
19.66%
Marge brute
80.89%
Autres analyses Peter Lynch
Questions fréquentes
What is ALNY's Peter Lynch fit score?
ALNY scores 79/100 on our Peter Lynch fit engine. Strong GARP candidate: growth at a reasonable price.
Does Peter Lynch actually own ALNY?
Our score is computed from financial fundamentals against Peter Lynch's published criteria. We don't claim that Peter Lynch personally owns or recommends ALNY.
How often is this score updated?
ALNY's Peter Lynch fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Outil éducatif, pas un conseil en investissement. Les scores sont calculés à partir de données financières publiques selon les critères publiés de chaque stratégie d'investissement. Nous ne prétendons pas que Peter Lynch possède ou recommande ALNY personnellement.
